Content specific to this active ingredient… Drug Information Prescribing and patient information from leading authorities Drug Master Files Type 2 master files on file at the FDA Drug Recalls For prescription drugs containing this active ingredient Exclusivity Patent and market exclusivity data Federal Register FR search results for this API FDA Approved Labelling Information found in this drug's package inserts Research Links Chemical identification and research citations Title 21 Code of Federal Regulations FDA regulations for this API

FDA Approval Activities for this Drug… Keppra (levetiracetam) Solution, UCB Pharma NDA 21-505 7/15/03 7/28/03 Keppra (levetiracetam) Tablets, UCB Pharma, NDA 21-035/S30 9/3/03 9/9/03 Keppra (levetiracetam) Tablets, UCB Pharma, NDA 21-035/S13 & S19 5/22/02 5/29/02 Keppra (levetiracetam) Tablets, 250 mg, 500 mg, and 750 mg. UCB Pharma, NDA 21-035 | Keppra (levetiracetam) Tablets, UCB Pharma, Inc., Labeling Revision | Keppra (levetiracetam) Oral Solution, UCB Pharma, Inc., Labeling Revision | Keppra (levetiracetam) tablets, UCB Pharma, Patient Population Altered | Keppra (levetiracetam) oral solution, UCB Pharma, Patient Population Altered | Keppra (levetiracetam) tablets, UCB, Inc., Formulation Revision | Keppra (levetiracetam) tablets, UCB, Inc., Labeling Revision | Keppra (levetiracetam) oral solution, UCB, Inc., Labeling Revision | Keppra (Levetiracetam) Injection, UCB, Inc., Approval | Keppra (levetiracetam) tablets, UCB, Inc., Labeling Revision | Keppra (levetiracetam) oral solution, UCB, Inc., Labeling Revision | Keppra (levetiracetam) Tablets, UCB Inc., New or Modified Indication | Keppra (levetiracetam) Oral Solution, UCB Inc., New or Modified Indication | Keppra (levetiracetam) Injection, UCB Inc., Labeling Revision | Keppra (levetiracetam) Tablets, UCB Inc., Labeling Revision | Keppra (levetiracetam) Oral Solution, UCB Inc., Labeling Revision | Keppra (levetiracetam) Injection, UCB, Inc., New or Modified Indication | Keppra XR (levetiracetam) Extended-Release Tablets, UCB, Inc., Approval | Levetiracetam Tablets, Mylan Pharmaceuticals Inc., Approval | Levetiracetam Tablets, Cobalt Laboratories, Inc., Tentative Approval | Levetiracetam Oral Solution, Roxane Laboratories, Inc., Approval | Levetiracetam Oral Solution, TOLMAR Inc., Approval | Levetiracetam Tablets, Aurobindo Pharma, Inc., Approval | Levetiracetam Tablets, Cobalt Laboratories, Inc., Approval | Levetiracetam Tablets, Dr. Reddy’s Laboratories Limited, Approval | Levetiracetam Tablets, Lupin Limited, Approval | Levetiracetam Tablets, Orchid Healthcare, Approval | Levetiracetam Tablets, Roxane Laboratories, Inc., Approval | Levetiracetam Tablets, Sandoz Inc., Approval | Levetiracetam Tablets, Torrent Pharmaceuticals Limited, Approval | Levetiracetam Oral Solution, Cypress Pharmaceutical, Inc., Approval | Levetiracetam Oral Solution, Actavis Mid Atlantic LLC, Approval | Levetiracetam Tablets, InvaGen Pharmaceuticals, Inc., Approval | Levetiracetam Tablets, Teva Pharmaceuticals, Approval | Levetiracetam Tablets, Wockhardt Ltd., Approval | Levetiracetam Oral Solution, Taro Pharmaceutical Industries, Ltd., Approval | Levetiracetam Tablets, Genpharm ULC, Approval | Levetiracetam Tablets, Solco Healthcare LLC, Approval | Keppra XR (levetiracetam) Extended-Release Tablets, UCB, Inc., Formulation Revision | Levetiracetam Tablets, Apotex Inc., Approval | Levetiracetam Tablets, Cipla Ltd., Approval | Keppra (levetiracetam) Tablets, UCB, Inc., Labeling Revision | Keppra (levetiracetam) Oral Solution, UCB, Inc., Labeling Revision | Keppra XR (levetiracetam) Extended-Release Tablets, UCB, Inc., Labeling Revision | Levetiracetam Tablets, Zydus Pharmaceuticals USA Inc., Approval ^ FDA's latest approval appears at the bottom of this list. ^   A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z Health Topics | News Feed for each API | DMF Index | Pharma Job Search | Pharma Company News © 2009 Betterchem.com